Literature DB >> 10074552

rpoB mutations in multidrug-resistant strains of Mycobacterium tuberculosis isolated in Italy.

G Pozzi1, M Meloni, E Iona, G Orrù, O F Thoresen, M L Ricci, M R Oggioni, L Fattorini, G Orefici.   

Abstract

Mutations of rpoB associated with rifampin resistance were studied in 37 multidrug-resistant (MDR) clinical strains of Mycobacterium tuberculosis isolated in Italy. At least one mutated codon was found in each MDR strain. It was always a single-base substitution leading to an amino acid change. Nine different rpoB alleles, three of which had not been reported before, were found. The relative frequencies of specific mutations in this sample were different from those previously reported from different geographical areas, since 22 strains (59.5%) carried the mutated codon TTG in position 531 (Ser-->Leu) and 11 (29.7%) had GAC in position 526 (His-->Asp).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10074552      PMCID: PMC88675     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  Relationship between rifampin MICs for and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan.

Authors:  H Ohno; H Koga; S Kohno; T Tashiro; K Hara
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

2.  Comparative antimycobacterial activities of rifampin, rifapentine, and KRM-1648 against a collection of rifampin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations.

Authors:  S L Moghazeh; X Pan; T Arain; C K Stover; J M Musser; B N Kreiswirth
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

3.  Detection of rifampin resistance among isolates of Mycobacterium tuberculosis from Mozambique.

Authors:  D A Caugant; P Sandven; J Eng; J T Jeque; T Tønjum
Journal:  Microb Drug Resist       Date:  1995       Impact factor: 3.431

4.  Evaluation of a line probe assay kit for characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from New York City.

Authors:  R C Cooksey; G P Morlock; S Glickman; J T Crawford
Journal:  J Clin Microbiol       Date:  1997-05       Impact factor: 5.948

5.  Disequilibria in the distribution of rpoB alleles in rifampicin-resistant M. tuberculosis isolates from Germany and Sierra Leone.

Authors:  H Rinder; P Dobner; K Feldmann; M Rifai; G Bretzel; S Rüsch-Gerdes; T Löscher
Journal:  Microb Drug Resist       Date:  1997       Impact factor: 3.431

6.  Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis.

Authors:  H Taniguchi; H Aramaki; Y Nikaido; Y Mizuguchi; M Nakamura; T Koga; S Yoshida
Journal:  FEMS Microbiol Lett       Date:  1996-10-15       Impact factor: 2.742

7.  Rapid prediction of rifampin susceptibility of Mycobacterium tuberculosis.

Authors:  H Ohno; H Koga; T Kuroita; K Tomono; K Ogawa; K Yanagihara; Y Yamamoto; J Miyamoto; T Tashiro; S Kohno
Journal:  Am J Respir Crit Care Med       Date:  1997-06       Impact factor: 21.405

8.  Detection of resistance to isoniazid, rifampin, and streptomycin in clinical isolates of Mycobacterium tuberculosis by molecular methods.

Authors:  I Nachamkin; C Kang; M P Weinstein
Journal:  Clin Infect Dis       Date:  1997-05       Impact factor: 9.079

9.  The primary structure of Escherichia coli RNA polymerase. Nucleotide sequence of the rpoB gene and amino-acid sequence of the beta-subunit.

Authors:  Y A Ovchinnikov; G S Monastyrskaya; V V Gubanov; S O Guryev; N N Modyanov; V A Grinkevich; I A Makarova; T V Marchenko; I N Polovnikova; V M Lipkin; E D Sverdlov
Journal:  Eur J Biochem       Date:  1981-06-01

10.  Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study.

Authors:  B Heym; N Honoré; C Truffot-Pernot; A Banerjee; C Schurra; W R Jacobs; J D van Embden; J H Grosset; S T Cole
Journal:  Lancet       Date:  1994-07-30       Impact factor: 79.321

View more
  37 in total

1.  Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence community.

Authors:  A Van Rie ; R Warren; I Mshanga; A M Jordaan; G D van der Spuy ; M Richardson; J Simpson; R P Gie; D A Enarson; N Beyers; P D van Helden ; T C Victor
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

2.  Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis clinical isolates from India.

Authors:  C Mani; N Selvakumar; S Narayanan; P R Narayanan
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

3.  rpoB genotypes of Mycobacterium tuberculosis Beijing family isolates from East Asian countries.

Authors:  Lishi Qian; Chiyoji Abe; Tao-Ping Lin; Ming-Chih Yu; Sang-Nae Cho; Sumin Wang; James T Douglas
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

4.  Molecular characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequencing and the line probe assay.

Authors:  Z Bártfai; A Somoskövi; C Ködmön; N Szabó; E Puskás; L Kosztolányi; E Faragó; J Mester; L M Parsons; M Salfinger
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

5.  Characterization of rpoB mutations in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Turkey by DNA sequencing and line probe assay.

Authors:  Cengiz Cavusoglu; Suleyha Hilmioglu; Sevinc Guneri; Altinay Bilgic
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

6.  Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis isolates from China.

Authors:  Jun Yue; Wei Shi; Jingping Xie; Yao Li; Erliang Zeng; Honghai Wang
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

7.  Genetic diversity of multidrug-resistant Mycobacterium tuberculosis isolates and identification of 11 novel rpoB alleles in Taiwan.

Authors:  Ruwen Jou; Huang-Yau Chen; Chen-Yuan Chiang; Ming-Chih Yu; Ih-Jen Su
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

8.  Use of genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy.

Authors:  Paolo Miotto; Federica Piana; Valeria Penati; Filippo Canducci; Giovanni Battista Migliori; Daniela Maria Cirillo
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

9.  Rifampin drug resistance tests for tuberculosis: challenging the gold standard.

Authors:  Armand Van Deun; Kya J M Aung; Valentin Bola; Rossin Lebeke; Mohamed Anwar Hossain; Willem Bram de Rijk; Leen Rigouts; Aysel Gumusboga; Gabriela Torrea; Bouke C de Jong
Journal:  J Clin Microbiol       Date:  2013-06-12       Impact factor: 5.948

10.  Visual detection of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis strains by use of an asymmetrically split peroxidase DNAzyme.

Authors:  Minggang Deng; Shuo Feng; Fengling Luo; Shaoru Wang; Xiaoming Sun; Xiang Zhou; Xiao-Lian Zhang
Journal:  J Clin Microbiol       Date:  2012-08-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.